Pasco County Patient Care Facility Largest in Statewide Network FORT MYERS, Fla., May 16, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) this week celebrated the opening of its newest patient care facility—the largest of the nearly 100 locations in its statewide network. The state-of-the-art FCS Wesley Chapel Cancer Center at 2895 Hueland Pond Boulevard, Suite 100, Wesley Chapel, FL 33543 provides a comprehensive range of personalized services for adults with can

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 16, 2025 /PRNewswire/ -- Equity Insider News Commentary – AI is no longer just assisting healthcare — it's beginning to rewire it from the ground up. From streamlining diagnostics and automating clinical documentation to predicting disease and optimizing hospital operations, generative AI is now touching every layer of the care continuum. As policymakers in places like Connecticut debate how to regulate

BRONX, N.Y., May 16, 2025 /PRNewswire/ -- Albert Einstein College of Medicine has appointed Britta Will, Ph.D., associate professor of oncology, of medicine and of cell biology, and the Diane and Arthur B. Belfer Scholar in Cancer Research, as the permanent director of the Ruth L. and David S. Gottesman Institute for Stem Cell Research and Regenerative Medicine. "After an extensive national search, Dr. Will emerged as the clear choice to lead our esteemed institute, which she has been a member

TAIPEI, May 16, 2025 /PRNewswire/ -- The broad-spectrum antiviral siRNA drug SNS812, co-developed by Oneness Biotech (4743.TW) and Microbio (Shanghai), has been selected for oral presentation at the prestigious 2025 American Thoracic Society (ATS) International Conference. The presentation will deliver the latest clinical data to leading global experts in the fields of respiratory and infectious diseases. SNS812 is the world's first fully modified siRNA drug, clinically validated and administere

WuXi Biologics’ 13,000-square-meter Leverkusen, Germany, site comes with a team of 150 employees. WuXi Biologics is giving CDMO Terumo the keys to its site in Leverkusen, Germany, with a 150 million euros ($167 million) sale.With the deal, WuXi Biologics can “exclusivity focus” on building large-scale global drug product manufacturing capacities in Singapore while optimizing returns on assets with future growth in mind, the company said in a release. The divesture marks the end of t

Positive data from a Pfizer-partnered antibody-drug conjugate, Roche's new investment in China and Hengrui's upcoming dual listing in Hong Kong made our news this week. Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. Roche plans to invest nearly $300 million to build a new Chinese plant to produce Vabysmo. China's Hengrui Pharma is looking to raise up to $1.27 billion in its Hong Kong IPO. And more.1. Pfizer partne

As Incyte CEO Hervé Hoppenot has previously told Fierce Pharma, the company does not expect Zynyz to be a major revenue driver. With two concurrent FDA approvals, Incyte’s PD-1 inhibitor Zynyz has redeemed itself in anal cancer four years after an initial snub from the agency.U.S. regulators have signed off on Zynyz, used in combination with platinum-based chemotherapy, for the first-line treatment of inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (S

TORONTO, May 16, 2025 /PRNewswire/ -- Recently, Visionary has achieved a significant breakthrough in the field of early cancer screening and home self - testing technologies, attracting widespread attention from the industry. American Precision Biotech Inc. is a subsidiary of Visionary Holdings. Since its establishment in 1996, the company has been dedicated to the research, development, production, and sales of early cancer screening and home self - testing technology products. It has a profess

Ultrasound Renal Denervation, a Proven Treatment for High Blood Pressure, is Available to Veterans Thanks to a Partnership Between Recor Medical and Recon Supply ST. CHARLES, Mo., May 16, 2025 /PRNewswire/ -- Hypertension, or high blood pressure, is known as the "silent killer" because many people do not know they have it and, over time, it can lead to serious health issues. In fact, hypertension increases the risk of heart disease and stroke, two of the leading causes of death in the United Sta

The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in addition to aneuploidies, as early as nine weeks into pregnancy — all from a single maternal blood sample MENLO PARK, Calif., May 16, 2025 /PRNewswire/ -- BillionToOne, Inc., a molecular diagnostics company with a mission to create the most powerful and accurate tests that are accessible to all, announced today the launch of an expanded offering for providers utiliz